Product
[177Lu]Lu-EVS459
1 clinical trial
2 indications
Indication
Ovarian CancerIndication
lung cancerClinical trial
A Phase I, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung CancersStatus: Not yet recruiting, Estimated PCD: 2030-08-30